18F-DCFPyL PSMA PET/CT在中危前列腺癌根治术中的诊断准确性:盆腔淋巴结清扫是否仍必要?
该研究纳入189例中危前列腺癌患者,比较18F-DCFPyL PSMA PET/CT与多参数MRI及三种列线图对淋巴结转移的诊断性能。PSMA PET/CT的灵敏度为80%、特异度为87%、AUC为0.83,优于其他模型;在161例PSMA阴性患者中,99%可安全省略盆腔淋巴结清扫。
要点
- PSMA PET/CT对中危前列腺癌淋巴结转移具有高特异度和高阴性预测值。
- PSMA阴性患者中99%可安全省略盆腔淋巴结清扫。
- PSMA PET/CT诊断性能优于多参数MRI和Briganti等列线图。
核心结论
- PSMA PET/CT具有高特异度和阴性预测值,可能安全指导PSMA阴性患者省略盆腔淋巴结清扫,但需前瞻性验证。
研究设计与样本
- 回顾性分析2022年1月至2023年12月间接受18F-DCFPyL PSMA PET/CT及根治性前列腺切除加双侧盆腔淋巴结清扫的中危前列腺癌患者189例。
主要发现
- 189例中28例(15%)PSMA阳性;病理证实4例PSMA阳性患者及1例PSMA阴性患者存在淋巴结转移。
- PSMA PET/CT的阳性预测值为14%(95% CI: 7.1%-22%),阴性预测值为99%(95% CI: 98%-100%)。
- PSMA PET/CT灵敏度80%(95% CI: 40%-100%),特异度87%(95% CI: 82%-91%),平衡准确度83%(95% CI: 63%-95%),AUC 0.83(95% CI: 0.64-1),优于其他模型。
- PSMA阴性患者中160/161例(99%)可安全省略盆腔淋巴结清扫;多参数MRI未检出阳性淋巴结。
临床怎么用
- 在中危前列腺癌患者中,可考虑使用18F-DCFPyL PSMA PET/CT评估淋巴结转移风险。
- 对于PSMA PET/CT阴性的患者,可考虑安全省略盆腔淋巴结清扫。
局限性
- 需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Pelvic lymph node dissection (PLND) remains standard for nodal staging in prostate cancer (PCa), yet its benefit in intermediate-risk PCa is controversial. Traditional imaging and nomograms often lack accuracy, resulting in unnecessary PLND. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/CT is a promising alternative. We compared its diagnostic performance and clinical utility with established risk models in intermediate-risk PCa. MATERIALS AND METHODS: We analyzed patients with intermediate-risk PCa who underwent [18F]-DCFPyL PSMA PET/CT and radical prostatectomy with bilateral PLND between January 2022 and December 2023. PSMA PET/CT results were classified as positive or negative for nodal involvement. Diagnostic performance was compared with multiparametric MRI, the Briganti 2012, Briganti 2023 nomograms, and the Memorial Sloan Kettering Cancer Center nomogram by sensitivity, specificity, positive predictive value, negative predictive value, accuracy, balanced accuracy, and AUC. RESULTS: Among 189 patients, 28 (15%) had PSMA-positive lymph nodes. Pathology confirmed metastases in 4 PSMA-positive patients (positive predictive value: 14%, 95% CI: 7.1%-22%) and 1 PSMA-negative patient (negative predictive value: 99%, 95% CI: 98%-100%). PSMA PET/CT demonstrated 80% sensitivity (95% CI: 40%-100%), 87% specificity (95% CI: 82%-91%), balanced accuracy of 83% (95% CI: 63%-95%), and an AUC of 0.83 (95% CI: 0.64-1), outperforming other models. PSMA would have safely omitted PLND in 160 of 161 (99%) PSMA-negative cases, whereas multiparametric MRI detected no positive nodes. CONCLUSIONS: PSMA PET/CT, with high specificity and negative predictive value, may safely guide PLND omission in PSMA-negative patients. Prospective validation is warranted.
引用
- Eraky A, Tillu N, Ben-David R, et al. Diagnostic Accuracy of [18F]-DCFPyL Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in Intermediate-Risk Prostate Cancer Undergoing Radical Prostatectomy: Is Pelvic Lymph Node Dissection Still Necessary? J Urol. 2025. PMID: 40623296. doi:10.1097/JU.0000000000004659
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。